National Comprehensive Cancer Network
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
Contenu en anglais
Résumé
The NCCN Guidelines for Thyroid Carcinoma address the management of different types of thyroid carcinoma, including papillary, follicular, oncocytic, medullary, and anaplastic carcinoma. The NCCN Thyroid Carcinoma Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights focus on the panel's most recent recommendations regarding systemic therapies for thyroid carcinoma as well as the supporting clinical data.
Source et droits
Publiée par Journal of the National Comprehensive Cancer Network : JNCCN, 2025. La recommandation elle-même se trouve à la source indiquée ici.
Prognia résume cette recommandation à des fins de consultation et d’enseignement. Il ne s’agit pas d’un avis médical. Vérifiez toujours la recommandation officielle et les protocoles locaux en vigueur avant de l’appliquer.
En bref
- Organisme
- National Comprehensive Cancer Network
- Date de publication
- 2025
- S’applique à
- 🇺🇸 États-Unis
- Portée
- Nationale
- Revue
- Journal of the National Comprehensive Cancer Network : JNCCN
- PubMed
- 40639400
Autres recommandations en oncologie
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
